TNFRSF1A and neoplasm: Supporting this possibility are many studies of patients suffering of autoimmune/inflammatory diseases, demonstrating that inhibition of the TNFα-TNFR pathway was not significantly associated with increased tumor risk or recurrence (with some, yet unsubstantiated, reservations regarding non-melanoma skin cancer and lymphoma) (75–81).